Asset Details
Do you wish to reserve the book?
Beneficial Effect of Olive Leaf Extract as an Adjunct to Standard Antifungal Therapy in Treating Candida-Related Oral Diseases
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Beneficial Effect of Olive Leaf Extract as an Adjunct to Standard Antifungal Therapy in Treating Candida-Related Oral Diseases
Do you wish to request the book?
Beneficial Effect of Olive Leaf Extract as an Adjunct to Standard Antifungal Therapy in Treating Candida-Related Oral Diseases
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Beneficial Effect of Olive Leaf Extract as an Adjunct to Standard Antifungal Therapy in Treating Candida-Related Oral Diseases
2025
Overview
The aim of this study was to evaluate whether combined administration of olive leaf extract (OLE) with standard antifungal therapy—nystatin (NYS) or miconazole (MIC) could be a more efficient alternative in reducing the number of Candida colonies, the presence of oral signs and symptoms and changes in salivary IL-17A level compared to standard therapy alone. The study included 59 subjects with a positive microbiological Candida colony number greater than 600 CFU/mL and at least one oral sign or symptom present. Subjects were randomly divided into four groups depending on applied therapy: OLE + NYS group (n = 15), OLE + MIC group (n = 15), NYS group (n = 14), MIC group (n = 15). Therapy duration and clinical monitoring were standardized across all groups. There was no significant difference between the tested groups in Candida spp. colony number or salivary IL-17A levels. In the OLE + NYS group, a significant increase in salivation rate was observed, while a significant decrease in tongue burning was reported in the OLE + MIC group. A significant reduction in burning of the oral mucosa and tongue was observed in the MIC group. No significant differences were found in other clinical signs or symptoms among treatment groups. OLE, as an adjunct to standard antifungal therapy, did not significantly reduce Candida spp. colony number or salivary IL-17A levels. However, in combination with NYS it increased salivation rate, while in combination with miconazole, it significantly decreased tongue burning. Both symptoms are common clinical findings in oral Candida-related disease and suggest that OLE may have supportive potential in the clinical management of these conditions. Further research is needed to explore its potential therapeutic benefits on oral health.
Publisher
MDPI AG,Multidisciplinary Digital Publishing Institute (MDPI)
Subject
/ Aged
/ Antifungal Agents - pharmacology
/ Antifungal Agents - therapeutic use
/ Candidiasis, Oral - drug therapy
/ Candidiasis, Oral - microbiology
/ Croatia
/ Diseases
/ Drugs
/ Female
/ Humans
/ Illinois
/ Male
/ Miconazole - therapeutic use
/ Plant Extracts - administration & dosage
/ Plant Extracts - pharmacology
